Estimation of the real burden of invasive meningococcal disease in Argentina

J A Gómez1, P Wetzler Malbrán1, G Vidal1

  • 1GSK, Buenos Aires, Argentina.

Epidemiology and Infection
|November 30, 2019
PubMed

Insights

Invasive meningococcal disease (IMD) in Argentina is underestimated. This study adjusted surveillance data, revealing potentially 3.1 times more cases and 1.9 times more deaths than reported, emphasizing improved surveillance needs.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Invasive meningococcal disease (IMD), primarily caused by Neisseria meningitidis, poses a significant public health challenge.
  • Argentina reported an incidence of 0.44 cases per 100,000 inhabitants in 2015, likely an underestimation due to surveillance limitations.

Purpose of the Study:

  • To provide a more accurate estimation of the IMD burden in Argentina.
  • To adjust for underreporting and diagnostic limitations in existing surveillance data.

Main Methods:

  • A retrospective observational study utilized four national databases (2007-2016).
  • Data on IMD cases, deaths, serogroups, and age were analyzed.
  • Adjustments were made for underreporting and limitations in Neisseria meningitidis detection.

Main Results:

  • Estimated IMD cases were 3.1 times higher than reported.
  • Estimated IMD-related deaths were 1.9 times higher than reported.
  • Analysis included stratification by Neisseria meningitidis serogroups and age groups.

Conclusions:

  • The study corrects the historical underestimation of IMD's disease burden in Argentina.
  • Findings provide more robust estimates aligned with international data.
  • Highlights the critical need for active, high-quality surveillance to inform preventive strategies against IMD.